Interparfums, Inc.

IPAR

CIK 0000822663 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$386M
↑+6.8% +$25Mvs FY2024 (Q4)
Operating Income
$28M
↓-23.6% -$8Mvs FY2024 (Q4)
Net Income
$18M
↓-26.0% -$6Mvs FY2024 (Q4)
Gross Profit
$237M
↑+1.8% +$4Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Strong
68/100
  • Profitability
    81ROIC 21.2% (10% = solid, 20%+ = moat)
  • Liquidity
    100Current Ratio 2.99 (above 1.5 = solid)
  • Leverage
    90D/E 0.20 (under 0.5 = conservative)
  • Efficiency
    61Asset Turnover 0.99x (1.0+ = capital-efficient)
  • Growth
    39Revenue YoY +6.8% (10% = solid, 25%+ = elite)
  • Margin Trend
    39Op Margin 7.1% · trend -0.6pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project IPAR's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

25%

Trailing 3-yr CAGR was 69.3%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$197.70
Total enterprise IV
$6.35B
Diluted shares
0.03B
Terminal PV
$4.93B (78% of total)
Year-5 FCF
$581M
YearProjected FCFDiscounted PV
+1$238M$216M
+2$298M$246M
+3$372M$280M
+4$465M$318M
+5$581M$361M
Terminal$7.94B$4.93B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$24M
investment in PP&E
Dividends paid (TTM)
$103M
cash returned to holders
Stock buybacks (TTM)
$14M
share count reduction
Stock-based comp (TTM)
$2M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$1.59B
everything owned
Stockholders' equity
$881M
shareholder claim
Net debt
$96M
LT debt minus cash

Recent performance · 63 quarters

Revenue↑+6.8% +$25M
$386M
Net Income↑+16.0% +$4M
$28M
Free Cash Flow↑+6.5% +$9M
$145M
Operating Margin↓-2.8pts
7.1%

Drill down